FAST Study - Follow up and Active Surveillance of TIV
The FAST Study is a telephone survey of parents of children who have recently received the seasonal Trivalent Influenza Vaccine (TIV).
At the commencement of the seasonal 'flu vaccination programme, the Vaccine Trials Group contact a random sample of parents who attend the Rheola Street Central Immunisation Clinic to ask whether or not their children experience any side effects.
The aim of the study is the early identification of any problems with the current 'flu vaccines as well as providing parents and professionals with up to date information.
In 2014 FAST became part of AusVaxSafety, an enhanced
surveillance system to monitor adverse events following
immunisation with influenza vaccine in children under 5 years of
age. Using FAST data and also data from surveillance in New
South Wales and Victoria, AusVaxSafety reports to the Therapeutic
Goods Administration and publishes its results on their website.
AusVaxSaftey surveillance data from 2014 shows that seasonal influenza vaccine is safe in children under 5 years of age with reported reactions generally mild and resolving within 1 to 2 days. No serious vaccine reactions were reported.